KCI Biotech is a specialized preclinical CRO obesity partner. We leverage validated animal models of obesity, such as the diet-induced obesity mouse model, and advanced in vivo platforms to deliver robust obesity preclinical research services. Our extensive experience ensures reliable study design and data to accelerate your metabolic drug development projects. For comprehensive obesity CRO services, partner with us.
| Disease Name | Model Name | Animal Species | |||||||||
| Mouse | Rat | Hamster | Guinea Pig | Ferret | Rabbit | Cat | Dog | Pig | Non-human Primate | ||
| Obesity | High-fat diet-induced model | √ | √ | √ | |||||||
| ob/ob activity model | √ | ||||||||||
A: KCI Biotech provides established models including the diet-induced obesity mouse model (high-fat diet-induced), the ob/ob mouse obesity model, and other tailored disease model of obesity systems.
A: KCI Biotech is a dedicated preclinical CRO obesity expert. Our experience ensures reliable study design and data to accelerate your metabolic drug projects.
A: Our obesity preclinical research services include comprehensive metabolic profiling, tissue analysis, and efficacy evaluation within our obesity models CRO platform.
A: By leveraging deep expertise in obesity and metabolism mouse models CRO, KCI Biotech designs preclinical studies for obesity with clinically predictive endpoints to support translation.
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
